Five-year survival of patients with malignant hypertension treated with antihypertensive agents

In this article, Freis and Mohler, a medical student at Georgetown University, reported the findings of their five-year study on the survival rate among patients with malignant hypertension. They concluded that treatment with antihypertensive agents prior to renal failure greatly enhanced a patient's chances for survival, and even proved to provide a greater chance for patients who also had advanced atherosclerosis as a result of prolonged high blood pressure. Freis and Mohler also noted that African American patients who received treatment lived almost as long as white patients in the study.